A new laser Doppler perfusion imaging (LDI) system was evaluated by comparing it with the well-established radiolabelled microsphere technique for measuring blood flow in the rabbit knee joint capsule. In this study two laser sources (635 and 835 nm) were compared at three scan speeds (50, 10 and 4 ms/pixel). With blood flow to the rabbit hindlimb controlled via a peristaltic pump, the comparison of LDI and microsphere measurement techniques yielded highly significant correlations for both laser sources (r = 0.9; p = 0.0001; 14 measurements in 7 animals). Comparison of the three scan speeds demonstrated acceptable agreement without significant bias between measurements, suggesting that the inevitable narrowing of the bandwidth at the fastest scan speed does not cause significant deterioration of the signal. The flux values obtained with 635 and 835 nm laser sources were linearly related (r = 0.93, p = 0.0001; 66 measurements in 12 animals), although there was a small but significant bias for higher values with the 635-nm laser (mean ratio of flux values 1.06, 95% confidence interval 1.01-1.12). These results validate the use of LDI with either wavelength laser for the assessment of joint capsule perfusion.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.